
    
      This is a randomized, double-blind, placebo-controlled, dose ranging, multicenter study.
      Subjects will be assigned to one of ten treatment groups and vaccinated according to the
      study group designation. Treatments will remain the same for first and second vaccinations
      (alternating left and right sides).
    
  